|
|
|
|
Document Preview Warrant Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Warrant Agreement |
|||
|
Entities: |
Immune Response Corp.; Kirkpatrick & Lockhart; Pillsbury Winthrop LLP |
|||
|
Date: |
2001 |
|||
|
Size: |
Preview shows 7KB of 32KB total |
|||
|
Price: |
$32 |
|||
|
ID: |
#281211 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
WARRANT AGREEMENT
WARRANT AGREEMENT (this "Agreement"), dated as of November 9, 2001, by and
between The Immune Response Corporation, a Delaware corporation (the "Company"),
and Kevin Kimberlin Partners, L.P., a Delaware limited partnership (the "Warrant
Holder").
W I T N E S S E T H
WHEREAS, the parties have entered into that certain Note Purchase
Agreement, dated as of November 9, 2001, by and between the Company and the
Warrant Holder (the "Note Purchase Agreement"); and
WHEREAS, pursuant to the Note Purchase Agreement, the Warrant Holder has
agreed to loan to the Company Two Million ($2,000,000) Dollars (the "Loan
Amount"), subject to the issuance by the Company of a convertible secured
promissory note (the "Note"), and the Company has agreed to issue to the Warrant
Holder warrants (the "Warrants") to purchase 1,733,703 shares of the Company's
common stock, par value $.0025 per share (the "Common Stock"), which equals the
Loan Amount divided by eighty (80%) percent of the Exercise Price (as defined in
Section 1 hereof), subject to the terms set forth herein.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants
and promises contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties agree
as follows:
1. WARRANTS. The Company hereby grants to the Warrant Holder, subject to
the terms set forth herein, the right to purchase from the Company at any time
and from time to time after the date hereof until 5:00 p.m., New York City local
time, on November 9, 2011 (the "Expiration Date"), up to 1,733,703 fully paid
and non-assessable shares of Common Stock, subject to adjustment pursuant to
Section 3 hereof (the "Shares"), which number of Shares equals the Loan Amount
divided by eighty (80%) percent of the Exercise Price. For purposes of this
Agreement, the "Exercise Price" shall initially be $1.4420, which is equal to
the average of the closing bid prices of the Common Stock for the ten (10)
consecutive trading days immediately preceding the date hereof, subject to the
adjustments pursuant to Section 3 hereof.
2. EXERCISE OF WARRANTS.
2.1 EXERCISE. The Warrants may be exercised by the Warrant Holder,
in whole or in part, by delivering the Notice of Exercise purchase form,
attached as EXHIBIT A hereto, duly executed by the Warrant Holder to the Company
at its principal office, or at such other office as the Company may designate,
accompanied by payment, in cash or by wire transfer or check payable to the
order of the Company, of the amount obtained by multiplying the number of Shares
designated in the Notice of Exercise by the Exercise Price (the "Purchase
Price"). The Purchase Price may also be paid, in whole or in part, by delivery
of such purchase form and of shares of Common Stock owned by the Warrant Holder
having a Fair Market Value (as defined in Section 2.3 hereof) on the last
trading day ending the day immediately preceding the Exercise Date (as defined
below) equal to the portion of the Purchase Price being paid in such shares. In
addition, the Warrants may be exercised, pursuant to a cashless exercise except
{Page}
as set forth in Section 3.3(4) below, by providing irrevocable instructions to
the Company, through delivery of the aforesaid purchase form with an appropriate
reference to this Section 2.1 to issue the number of shares of the Common Stock
equal to the product of (a) the number of shares as to which the Warrants are
being exercised multiplied by (b) a fraction, the numerator of which is the Fair
Market Value of a share of the Common Stock on the last business day preceding
the Exercise Date less the Exercise Price therefor and the denominator of which
is such Fair Market Value. For purposes hereof, "Exercise Date" shall mean the
date on which all deliveries required to be made to the Company upon exercise of
Warrants pursuant to this Section 2.1 shall have been made.
2.2 ISSUANCE OF CERTIFICATES. As soon as practicable after the
exercise of the Warrants (in whole or in part) in accordance with Section 2.1
hereof, the Company, at its expense, shall cause to be issued in the name of and
delivered to the Warrant Holder (i) a certificate or certificates for the number
of fully paid and non-assessable Shares to which the Warrant Holder shall be
entitled upon such exercise and (if applicable) (ii) a new warrant agreement of
like tenor to purchase all of the Shares that may be purchased pursuant to the
portion, if any, of the Warrants not exercised by the Warrant Holder. The
Warrant Holder shall for all purposes be deemed to have become the holder of
record of such Shares on the date on which the Notice of Exercise and payment of
the Purchase Price in accordance with Section 2.1 hereof were delivered and
made, respectively, irrespective of the date of delivery of such certificate or
certificates, except that if the date of such delivery, notice and payment is a
date when the stock transfer books of the Company are closed, such person shall
be deemed to have become the holder of record of such Shares at the close of
business on the next succeeding date on which the stock transfer books are open.
2.3 FAIR MARKET VALUE. The "Fair Market Value" of a share of Common
Stock on any day means: (a) if the principal market for the Common Stock is The
Nasdaq National Market or any other national securities exchange, the last sales
price of the Common Stock on such day as reported by such exchange or market, or
on a consolidated tape reflecting transactions on such exchange or market, or
(b) if the principal market for the Common Stock is not a national securities
exchange or The Nasdaq National Market and the Common Stock is quoted on the
National Association of Securities Dealers Automated Quotations System, the mean
between the closing bid and the closing asked prices for the Common Stock on
such day as quoted on such System, or (c) if the Common Stock is not quoted on
the National Association of Securities Dealers Automated Quotations System, the
mean between the highest bid and lowest asked prices for the Common Stock on
|
End of Preview |
Home Intelligence Services Subscriptions News About Us